These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10968709)

  • 1. Immunophenotyping of hematopoietic neoplasms.
    Chu PG; Chang KL; Arber DA; Weiss LM
    Semin Diagn Pathol; 2000 Aug; 17(3):236-56. PubMed ID: 10968709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry.
    Nguyen AN; Milam JD; Johnson KA; Banez EI
    Am J Clin Pathol; 2000 Jan; 113(1):95-106. PubMed ID: 10631862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in the immunophenotypic analysis of haematological malignancies.
    Heel K; Tabone T; Röhrig KJ; Maslen PG; Meehan K; Grimwade LF; Erber WN
    Blood Rev; 2013 Jul; 27(4):193-207. PubMed ID: 23845589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections.
    Pileri S; Falini B; Sabattini E; Bigerna B; Gherlinzoni F; Tazzari PL
    Haematologica; 1991; 76(3):226-34. PubMed ID: 1743593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies and immunohistochemical evaluation for the diagnosis of hematological malignancies: an overview.
    O'Malley DP; Orazi A
    Methods Mol Biol; 2007; 378():91-123. PubMed ID: 18605081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance.
    Kusenda J
    Neoplasma; 2008; 55(5):381-6. PubMed ID: 18665747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunophenotyping of haematologic malignancies].
    Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphology and immunophenotyping in hematological malignancies].
    Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
    Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.
    Frizzera G; Wu CD; Inghirami G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S13-39. PubMed ID: 9894467
    [No Abstract]   [Full Text] [Related]  

  • 10. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
    Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia.
    Wilson WH
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S2. PubMed ID: 17803186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Flow cytometric analysis of cell surface antigens].
    Yoneyama A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():843-6. PubMed ID: 20942202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematopoietic malignancy (leukemia, malignant lymphoma, multiple myeloma)].
    Nosaka K; Kawaguchi T
    Nihon Rinsho; 2012 May; 70(5):835-9. PubMed ID: 22620009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical uses of flow cytometry in hematological oncology].
    D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
    Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated immunostaining of cell smears: an alternative to flow cytometry.
    Happerfield LC; Saward R; Grimwade L; Bloxham D; Erber WN
    J Clin Pathol; 2008 Jun; 61(6):740-3. PubMed ID: 18326018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the application of immunohistochemical markers for the diagnosis of soft tissue tumors.
    Suster S
    Semin Diagn Pathol; 2000 Aug; 17(3):225-35. PubMed ID: 10968708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers in haematological malignancies.
    Lemal R; Tournilhac O; Bay JO
    Bull Cancer; 2014 Jun; 101 Suppl 1():S7-11. PubMed ID: 24966076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy.
    Fend F; Kremer M
    Pathobiology; 2007; 74(2):133-43. PubMed ID: 17587884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
    Jevremovic D; Viswanatha DS
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.